nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP1A2—Imiquimod—skin cancer	0.115	0.135	CbGbCtD
Tranylcypromine—CYP2C19—Vismodegib—skin cancer	0.0864	0.101	CbGbCtD
Tranylcypromine—CYP2E1—Dacarbazine—skin cancer	0.0835	0.0977	CbGbCtD
Tranylcypromine—CYP2A6—Fluorouracil—skin cancer	0.0742	0.0868	CbGbCtD
Tranylcypromine—CYP2C9—Vismodegib—skin cancer	0.0718	0.084	CbGbCtD
Tranylcypromine—CYP1A2—Vemurafenib—skin cancer	0.063	0.0737	CbGbCtD
Tranylcypromine—CYP3A4—Temozolomide—skin cancer	0.0602	0.0705	CbGbCtD
Tranylcypromine—CYP3A4—Imiquimod—skin cancer	0.0602	0.0705	CbGbCtD
Tranylcypromine—CYP2D6—Vemurafenib—skin cancer	0.0519	0.0608	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—skin cancer	0.0483	0.0565	CbGbCtD
Tranylcypromine—CYP3A4—Vismodegib—skin cancer	0.0418	0.0489	CbGbCtD
Tranylcypromine—CYP3A4—Vemurafenib—skin cancer	0.033	0.0386	CbGbCtD
Tranylcypromine—CYP1A2—Fluorouracil—skin cancer	0.0283	0.0331	CbGbCtD
Tranylcypromine—CYP2C9—Fluorouracil—skin cancer	0.0255	0.0299	CbGbCtD
Tranylcypromine—CYP3A4—Docetaxel—skin cancer	0.0113	0.0133	CbGbCtD
Tranylcypromine—Memory loss—Fluorouracil—skin cancer	0.00401	0.0279	CcSEcCtD
Tranylcypromine—Haemorrhage intracranial—Temozolomide—skin cancer	0.00312	0.0217	CcSEcCtD
Tranylcypromine—Tenderness—Imiquimod—skin cancer	0.00244	0.017	CcSEcCtD
Tranylcypromine—Ethotoin—SCN10A—skin cancer	0.00207	1	CrCbGaD
Tranylcypromine—Alopecia—Vismodegib—skin cancer	0.0018	0.0125	CcSEcCtD
Tranylcypromine—Tenderness—Bleomycin—skin cancer	0.00174	0.0121	CcSEcCtD
Tranylcypromine—Muscle spasms—Vismodegib—skin cancer	0.0017	0.0118	CcSEcCtD
Tranylcypromine—Urinary retention—Imiquimod—skin cancer	0.00147	0.0103	CcSEcCtD
Tranylcypromine—Numbness—Fluorouracil—skin cancer	0.00142	0.00989	CcSEcCtD
Tranylcypromine—Sensory loss—Fluorouracil—skin cancer	0.00136	0.00947	CcSEcCtD
Tranylcypromine—Tenderness—Fluorouracil—skin cancer	0.00135	0.0094	CcSEcCtD
Tranylcypromine—Decreased appetite—Vismodegib—skin cancer	0.00126	0.00874	CcSEcCtD
Tranylcypromine—Pain—Vismodegib—skin cancer	0.00123	0.0086	CcSEcCtD
Tranylcypromine—Constipation—Vismodegib—skin cancer	0.00123	0.0086	CcSEcCtD
Tranylcypromine—Urinary incontinence—Temozolomide—skin cancer	0.00123	0.00859	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Imiquimod—skin cancer	0.00123	0.00858	CcSEcCtD
Tranylcypromine—Disorientation—Bleomycin—skin cancer	0.00123	0.00856	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vismodegib—skin cancer	0.00118	0.00822	CcSEcCtD
Tranylcypromine—Abdominal pain—Vismodegib—skin cancer	0.00114	0.00795	CcSEcCtD
Tranylcypromine—Chills—Vemurafenib—skin cancer	0.00113	0.00785	CcSEcCtD
Tranylcypromine—Alopecia—Vemurafenib—skin cancer	0.00111	0.00773	CcSEcCtD
Tranylcypromine—Haemoglobin—Imiquimod—skin cancer	0.00108	0.0075	CcSEcCtD
Tranylcypromine—Haemorrhage—Imiquimod—skin cancer	0.00107	0.00746	CcSEcCtD
Tranylcypromine—Asthenia—Vismodegib—skin cancer	0.00104	0.00722	CcSEcCtD
Tranylcypromine—Tinnitus—Imiquimod—skin cancer	0.000998	0.00695	CcSEcCtD
Tranylcypromine—Flushing—Imiquimod—skin cancer	0.000994	0.00692	CcSEcCtD
Tranylcypromine—Diarrhoea—Vismodegib—skin cancer	0.000988	0.00688	CcSEcCtD
Tranylcypromine—Amnesia—Temozolomide—skin cancer	0.000987	0.00688	CcSEcCtD
Tranylcypromine—Chills—Imiquimod—skin cancer	0.000961	0.00669	CcSEcCtD
Tranylcypromine—Disorientation—Fluorouracil—skin cancer	0.000955	0.00665	CcSEcCtD
Tranylcypromine—Alopecia—Imiquimod—skin cancer	0.000946	0.00659	CcSEcCtD
Tranylcypromine—Vomiting—Vismodegib—skin cancer	0.000918	0.00639	CcSEcCtD
Tranylcypromine—Rash—Vismodegib—skin cancer	0.000911	0.00634	CcSEcCtD
Tranylcypromine—Amnesia—Fluorouracil—skin cancer	0.00091	0.00634	CcSEcCtD
Tranylcypromine—Dermatitis—Vismodegib—skin cancer	0.00091	0.00633	CcSEcCtD
Tranylcypromine—Ataxia—Temozolomide—skin cancer	0.000872	0.00607	CcSEcCtD
Tranylcypromine—Nausea—Vismodegib—skin cancer	0.000858	0.00597	CcSEcCtD
Tranylcypromine—Agitation—Imiquimod—skin cancer	0.000857	0.00597	CcSEcCtD
Tranylcypromine—Blood pressure increased—Docetaxel—skin cancer	0.00085	0.00592	CcSEcCtD
Tranylcypromine—Syncope—Imiquimod—skin cancer	0.000836	0.00582	CcSEcCtD
Tranylcypromine—Hypotension—Vemurafenib—skin cancer	0.000834	0.00581	CcSEcCtD
Tranylcypromine—Palpitations—Imiquimod—skin cancer	0.000824	0.00574	CcSEcCtD
Tranylcypromine—Loss of consciousness—Imiquimod—skin cancer	0.000819	0.00571	CcSEcCtD
Tranylcypromine—Hypertension—Imiquimod—skin cancer	0.000805	0.0056	CcSEcCtD
Tranylcypromine—Ataxia—Fluorouracil—skin cancer	0.000804	0.0056	CcSEcCtD
Tranylcypromine—Anxiety—Imiquimod—skin cancer	0.000791	0.00551	CcSEcCtD
Tranylcypromine—Dry mouth—Imiquimod—skin cancer	0.000776	0.00541	CcSEcCtD
Tranylcypromine—Decreased appetite—Vemurafenib—skin cancer	0.000776	0.0054	CcSEcCtD
Tranylcypromine—Haemoglobin—Bleomycin—skin cancer	0.000765	0.00532	CcSEcCtD
Tranylcypromine—Constipation—Vemurafenib—skin cancer	0.000763	0.00531	CcSEcCtD
Tranylcypromine—Oedema—Imiquimod—skin cancer	0.000761	0.0053	CcSEcCtD
Tranylcypromine—Haemorrhage—Bleomycin—skin cancer	0.000761	0.0053	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Bleomycin—skin cancer	0.000757	0.00527	CcSEcCtD
Tranylcypromine—Shock—Imiquimod—skin cancer	0.000749	0.00521	CcSEcCtD
Tranylcypromine—Tachycardia—Imiquimod—skin cancer	0.000743	0.00517	CcSEcCtD
Tranylcypromine—Pollakiuria—Temozolomide—skin cancer	0.000741	0.00516	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Temozolomide—skin cancer	0.000738	0.00514	CcSEcCtD
Tranylcypromine—Agranulocytosis—Dactinomycin—skin cancer	0.000738	0.00514	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Imiquimod—skin cancer	0.000736	0.00512	CcSEcCtD
Tranylcypromine—Anorexia—Imiquimod—skin cancer	0.000725	0.00505	CcSEcCtD
Tranylcypromine—Hepatitis—Dactinomycin—skin cancer	0.00071	0.00494	CcSEcCtD
Tranylcypromine—Flushing—Bleomycin—skin cancer	0.000706	0.00492	CcSEcCtD
Tranylcypromine—Body temperature increased—Vemurafenib—skin cancer	0.000705	0.00491	CcSEcCtD
Tranylcypromine—Insomnia—Imiquimod—skin cancer	0.000688	0.00479	CcSEcCtD
Tranylcypromine—Paraesthesia—Imiquimod—skin cancer	0.000683	0.00476	CcSEcCtD
Tranylcypromine—Chills—Bleomycin—skin cancer	0.000683	0.00475	CcSEcCtD
Tranylcypromine—Somnolence—Imiquimod—skin cancer	0.000676	0.00471	CcSEcCtD
Tranylcypromine—Alopecia—Bleomycin—skin cancer	0.000672	0.00468	CcSEcCtD
Tranylcypromine—Decreased appetite—Imiquimod—skin cancer	0.000661	0.00461	CcSEcCtD
Tranylcypromine—Flushing—Dactinomycin—skin cancer	0.000659	0.00459	CcSEcCtD
Tranylcypromine—Pain—Imiquimod—skin cancer	0.000651	0.00453	CcSEcCtD
Tranylcypromine—Haemoglobin—Temozolomide—skin cancer	0.000645	0.00449	CcSEcCtD
Tranylcypromine—Hepatitis—Temozolomide—skin cancer	0.000642	0.00447	CcSEcCtD
Tranylcypromine—Haemorrhage—Temozolomide—skin cancer	0.000642	0.00447	CcSEcCtD
Tranylcypromine—Asthenia—Vemurafenib—skin cancer	0.00064	0.00446	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Temozolomide—skin cancer	0.000639	0.00445	CcSEcCtD
Tranylcypromine—Chills—Dactinomycin—skin cancer	0.000637	0.00443	CcSEcCtD
Tranylcypromine—Alopecia—Dactinomycin—skin cancer	0.000627	0.00437	CcSEcCtD
Tranylcypromine—Feeling abnormal—Imiquimod—skin cancer	0.000627	0.00437	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Imiquimod—skin cancer	0.000622	0.00433	CcSEcCtD
Tranylcypromine—Agranulocytosis—Fluorouracil—skin cancer	0.000615	0.00428	CcSEcCtD
Tranylcypromine—Anaemia—Bleomycin—skin cancer	0.000612	0.00426	CcSEcCtD
Tranylcypromine—Diarrhoea—Vemurafenib—skin cancer	0.00061	0.00425	CcSEcCtD
Tranylcypromine—Urticaria—Imiquimod—skin cancer	0.000604	0.00421	CcSEcCtD
Tranylcypromine—Body temperature increased—Imiquimod—skin cancer	0.000601	0.00419	CcSEcCtD
Tranylcypromine—Abdominal pain—Imiquimod—skin cancer	0.000601	0.00419	CcSEcCtD
Tranylcypromine—Tinnitus—Temozolomide—skin cancer	0.000598	0.00417	CcSEcCtD
Tranylcypromine—Flushing—Temozolomide—skin cancer	0.000596	0.00415	CcSEcCtD
Tranylcypromine—Haemoglobin—Fluorouracil—skin cancer	0.000594	0.00414	CcSEcCtD
Tranylcypromine—Leukopenia—Bleomycin—skin cancer	0.000593	0.00413	CcSEcCtD
Tranylcypromine—Haemorrhage—Fluorouracil—skin cancer	0.000591	0.00412	CcSEcCtD
Tranylcypromine—Dizziness—Vemurafenib—skin cancer	0.00059	0.00411	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Fluorouracil—skin cancer	0.000588	0.0041	CcSEcCtD
Tranylcypromine—Ataxia—Docetaxel—skin cancer	0.00058	0.00404	CcSEcCtD
Tranylcypromine—Chills—Temozolomide—skin cancer	0.000576	0.00401	CcSEcCtD
Tranylcypromine—Anaemia—Dactinomycin—skin cancer	0.000571	0.00398	CcSEcCtD
Tranylcypromine—Vomiting—Vemurafenib—skin cancer	0.000567	0.00395	CcSEcCtD
Tranylcypromine—Alopecia—Temozolomide—skin cancer	0.000567	0.00395	CcSEcCtD
Tranylcypromine—Rash—Vemurafenib—skin cancer	0.000563	0.00392	CcSEcCtD
Tranylcypromine—Dermatitis—Vemurafenib—skin cancer	0.000562	0.00391	CcSEcCtD
Tranylcypromine—Headache—Vemurafenib—skin cancer	0.000559	0.00389	CcSEcCtD
Tranylcypromine—Leukopenia—Dactinomycin—skin cancer	0.000553	0.00385	CcSEcCtD
Tranylcypromine—Asthenia—Imiquimod—skin cancer	0.000546	0.0038	CcSEcCtD
Tranylcypromine—Confusional state—Bleomycin—skin cancer	0.000545	0.0038	CcSEcCtD
Tranylcypromine—Oedema—Bleomycin—skin cancer	0.000541	0.00376	CcSEcCtD
Tranylcypromine—Nausea—Vemurafenib—skin cancer	0.00053	0.00369	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Bleomycin—skin cancer	0.000529	0.00369	CcSEcCtD
Tranylcypromine—Vision blurred—Temozolomide—skin cancer	0.000527	0.00367	CcSEcCtD
Tranylcypromine—Tremor—Temozolomide—skin cancer	0.000523	0.00364	CcSEcCtD
Tranylcypromine—Alopecia—Fluorouracil—skin cancer	0.000523	0.00364	CcSEcCtD
Tranylcypromine—Diarrhoea—Imiquimod—skin cancer	0.000521	0.00363	CcSEcCtD
Tranylcypromine—Anaemia—Temozolomide—skin cancer	0.000516	0.0036	CcSEcCtD
Tranylcypromine—Anorexia—Bleomycin—skin cancer	0.000515	0.00359	CcSEcCtD
Tranylcypromine—Agitation—Temozolomide—skin cancer	0.000513	0.00358	CcSEcCtD
Tranylcypromine—Hypotension—Bleomycin—skin cancer	0.000505	0.00352	CcSEcCtD
Tranylcypromine—Oedema—Dactinomycin—skin cancer	0.000504	0.00351	CcSEcCtD
Tranylcypromine—Dizziness—Imiquimod—skin cancer	0.000503	0.0035	CcSEcCtD
Tranylcypromine—Leukopenia—Temozolomide—skin cancer	0.0005	0.00348	CcSEcCtD
Tranylcypromine—Palpitations—Temozolomide—skin cancer	0.000494	0.00344	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Dactinomycin—skin cancer	0.000494	0.00344	CcSEcCtD
Tranylcypromine—Paraesthesia—Bleomycin—skin cancer	0.000485	0.00338	CcSEcCtD
Tranylcypromine—Vision blurred—Fluorouracil—skin cancer	0.000485	0.00338	CcSEcCtD
Tranylcypromine—Vomiting—Imiquimod—skin cancer	0.000484	0.00337	CcSEcCtD
Tranylcypromine—Hypertension—Temozolomide—skin cancer	0.000482	0.00336	CcSEcCtD
Tranylcypromine—Anorexia—Dactinomycin—skin cancer	0.000481	0.00335	CcSEcCtD
Tranylcypromine—Rash—Imiquimod—skin cancer	0.00048	0.00334	CcSEcCtD
Tranylcypromine—Dermatitis—Imiquimod—skin cancer	0.000479	0.00334	CcSEcCtD
Tranylcypromine—Headache—Imiquimod—skin cancer	0.000477	0.00332	CcSEcCtD
Tranylcypromine—Anaemia—Fluorouracil—skin cancer	0.000476	0.00331	CcSEcCtD
Tranylcypromine—Anxiety—Temozolomide—skin cancer	0.000474	0.0033	CcSEcCtD
Tranylcypromine—Decreased appetite—Bleomycin—skin cancer	0.00047	0.00327	CcSEcCtD
Tranylcypromine—Dry mouth—Temozolomide—skin cancer	0.000465	0.00324	CcSEcCtD
Tranylcypromine—Pain—Bleomycin—skin cancer	0.000462	0.00322	CcSEcCtD
Tranylcypromine—Leukopenia—Fluorouracil—skin cancer	0.000461	0.00321	CcSEcCtD
Tranylcypromine—Confusional state—Temozolomide—skin cancer	0.00046	0.0032	CcSEcCtD
Tranylcypromine—Oedema—Temozolomide—skin cancer	0.000456	0.00318	CcSEcCtD
Tranylcypromine—Nausea—Imiquimod—skin cancer	0.000452	0.00315	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Temozolomide—skin cancer	0.000446	0.00311	CcSEcCtD
Tranylcypromine—Feeling abnormal—Bleomycin—skin cancer	0.000445	0.0031	CcSEcCtD
Tranylcypromine—Agranulocytosis—Docetaxel—skin cancer	0.000444	0.00309	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Temozolomide—skin cancer	0.000441	0.00307	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—skin cancer	0.000438	0.00305	CcSEcCtD
Tranylcypromine—Anorexia—Temozolomide—skin cancer	0.000435	0.00303	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—skin cancer	0.000431	0.003	CcSEcCtD
Tranylcypromine—Urticaria—Bleomycin—skin cancer	0.000429	0.00299	CcSEcCtD
Tranylcypromine—Haemoglobin—Docetaxel—skin cancer	0.000429	0.00299	CcSEcCtD
Tranylcypromine—Body temperature increased—Bleomycin—skin cancer	0.000427	0.00298	CcSEcCtD
Tranylcypromine—Haemorrhage—Docetaxel—skin cancer	0.000427	0.00297	CcSEcCtD
Tranylcypromine—Hepatitis—Docetaxel—skin cancer	0.000427	0.00297	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Docetaxel—skin cancer	0.000425	0.00296	CcSEcCtD
Tranylcypromine—Confusional state—Fluorouracil—skin cancer	0.000424	0.00295	CcSEcCtD
Tranylcypromine—Oedema—Fluorouracil—skin cancer	0.00042	0.00293	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—skin cancer	0.000415	0.00289	CcSEcCtD
Tranylcypromine—Insomnia—Temozolomide—skin cancer	0.000412	0.00287	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000412	0.00287	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fluorouracil—skin cancer	0.000411	0.00286	CcSEcCtD
Tranylcypromine—Tachycardia—Fluorouracil—skin cancer	0.00041	0.00286	CcSEcCtD
Tranylcypromine—Paraesthesia—Temozolomide—skin cancer	0.000409	0.00285	CcSEcCtD
Tranylcypromine—Somnolence—Temozolomide—skin cancer	0.000405	0.00282	CcSEcCtD
Tranylcypromine—Anorexia—Fluorouracil—skin cancer	0.0004	0.00279	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—skin cancer	0.000399	0.00278	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—skin cancer	0.000399	0.00278	CcSEcCtD
Tranylcypromine—Decreased appetite—Temozolomide—skin cancer	0.000396	0.00276	CcSEcCtD
Tranylcypromine—Flushing—Docetaxel—skin cancer	0.000396	0.00276	CcSEcCtD
Tranylcypromine—Hypotension—Fluorouracil—skin cancer	0.000393	0.00273	CcSEcCtD
Tranylcypromine—Pain—Temozolomide—skin cancer	0.00039	0.00272	CcSEcCtD
Tranylcypromine—Constipation—Temozolomide—skin cancer	0.00039	0.00272	CcSEcCtD
Tranylcypromine—Asthenia—Bleomycin—skin cancer	0.000388	0.0027	CcSEcCtD
Tranylcypromine—Chills—Docetaxel—skin cancer	0.000383	0.00267	CcSEcCtD
Tranylcypromine—Insomnia—Fluorouracil—skin cancer	0.00038	0.00265	CcSEcCtD
Tranylcypromine—Paraesthesia—Fluorouracil—skin cancer	0.000377	0.00263	CcSEcCtD
Tranylcypromine—Alopecia—Docetaxel—skin cancer	0.000377	0.00263	CcSEcCtD
Tranylcypromine—Feeling abnormal—Temozolomide—skin cancer	0.000376	0.00262	CcSEcCtD
Tranylcypromine—Somnolence—Fluorouracil—skin cancer	0.000373	0.0026	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Temozolomide—skin cancer	0.000373	0.0026	CcSEcCtD
Tranylcypromine—Decreased appetite—Fluorouracil—skin cancer	0.000365	0.00254	CcSEcCtD
Tranylcypromine—Urticaria—Temozolomide—skin cancer	0.000362	0.00252	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—skin cancer	0.000362	0.00252	CcSEcCtD
Tranylcypromine—Abdominal pain—Temozolomide—skin cancer	0.00036	0.00251	CcSEcCtD
Tranylcypromine—Body temperature increased—Temozolomide—skin cancer	0.00036	0.00251	CcSEcCtD
Tranylcypromine—Pain—Fluorouracil—skin cancer	0.000359	0.0025	CcSEcCtD
Tranylcypromine—Muscle spasms—Docetaxel—skin cancer	0.000357	0.00249	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fluorouracil—skin cancer	0.000346	0.00241	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—skin cancer	0.000345	0.0024	CcSEcCtD
Tranylcypromine—Vomiting—Bleomycin—skin cancer	0.000344	0.00239	CcSEcCtD
Tranylcypromine—Anaemia—Docetaxel—skin cancer	0.000343	0.00239	CcSEcCtD
Tranylcypromine—Rash—Bleomycin—skin cancer	0.000341	0.00237	CcSEcCtD
Tranylcypromine—Dermatitis—Bleomycin—skin cancer	0.00034	0.00237	CcSEcCtD
Tranylcypromine—Urticaria—Fluorouracil—skin cancer	0.000334	0.00232	CcSEcCtD
Tranylcypromine—Syncope—Docetaxel—skin cancer	0.000333	0.00232	CcSEcCtD
Tranylcypromine—Leukopenia—Docetaxel—skin cancer	0.000333	0.00232	CcSEcCtD
Tranylcypromine—Body temperature increased—Fluorouracil—skin cancer	0.000332	0.00231	CcSEcCtD
Tranylcypromine—Palpitations—Docetaxel—skin cancer	0.000328	0.00229	CcSEcCtD
Tranylcypromine—Asthenia—Temozolomide—skin cancer	0.000327	0.00228	CcSEcCtD
Tranylcypromine—Loss of consciousness—Docetaxel—skin cancer	0.000327	0.00227	CcSEcCtD
Tranylcypromine—Nausea—Bleomycin—skin cancer	0.000321	0.00224	CcSEcCtD
Tranylcypromine—Hypertension—Docetaxel—skin cancer	0.000321	0.00223	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—skin cancer	0.000321	0.00223	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—skin cancer	0.000318	0.00221	CcSEcCtD
Tranylcypromine—Diarrhoea—Temozolomide—skin cancer	0.000312	0.00217	CcSEcCtD
Tranylcypromine—Dry mouth—Docetaxel—skin cancer	0.000309	0.00215	CcSEcCtD
Tranylcypromine—Confusional state—Docetaxel—skin cancer	0.000306	0.00213	CcSEcCtD
Tranylcypromine—Oedema—Docetaxel—skin cancer	0.000303	0.00211	CcSEcCtD
Tranylcypromine—Dizziness—Temozolomide—skin cancer	0.000302	0.0021	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—skin cancer	0.000299	0.00209	CcSEcCtD
Tranylcypromine—Shock—Docetaxel—skin cancer	0.000298	0.00208	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Docetaxel—skin cancer	0.000297	0.00207	CcSEcCtD
Tranylcypromine—Tachycardia—Docetaxel—skin cancer	0.000296	0.00206	CcSEcCtD
Tranylcypromine—Vomiting—Temozolomide—skin cancer	0.00029	0.00202	CcSEcCtD
Tranylcypromine—Anorexia—Docetaxel—skin cancer	0.000289	0.00201	CcSEcCtD
Tranylcypromine—Rash—Temozolomide—skin cancer	0.000287	0.002	CcSEcCtD
Tranylcypromine—Diarrhoea—Fluorouracil—skin cancer	0.000287	0.002	CcSEcCtD
Tranylcypromine—Dermatitis—Temozolomide—skin cancer	0.000287	0.002	CcSEcCtD
Tranylcypromine—Headache—Temozolomide—skin cancer	0.000286	0.00199	CcSEcCtD
Tranylcypromine—Hypotension—Docetaxel—skin cancer	0.000283	0.00197	CcSEcCtD
Tranylcypromine—Dizziness—Fluorouracil—skin cancer	0.000278	0.00193	CcSEcCtD
Tranylcypromine—Insomnia—Docetaxel—skin cancer	0.000274	0.00191	CcSEcCtD
Tranylcypromine—Paraesthesia—Docetaxel—skin cancer	0.000272	0.0019	CcSEcCtD
Tranylcypromine—Nausea—Temozolomide—skin cancer	0.000271	0.00189	CcSEcCtD
Tranylcypromine—Somnolence—Docetaxel—skin cancer	0.00027	0.00188	CcSEcCtD
Tranylcypromine—Vomiting—Fluorouracil—skin cancer	0.000267	0.00186	CcSEcCtD
Tranylcypromine—Rash—Fluorouracil—skin cancer	0.000265	0.00184	CcSEcCtD
Tranylcypromine—Dermatitis—Fluorouracil—skin cancer	0.000265	0.00184	CcSEcCtD
Tranylcypromine—Decreased appetite—Docetaxel—skin cancer	0.000264	0.00184	CcSEcCtD
Tranylcypromine—Headache—Fluorouracil—skin cancer	0.000263	0.00183	CcSEcCtD
Tranylcypromine—Pain—Docetaxel—skin cancer	0.000259	0.00181	CcSEcCtD
Tranylcypromine—Constipation—Docetaxel—skin cancer	0.000259	0.00181	CcSEcCtD
Tranylcypromine—Feeling abnormal—Docetaxel—skin cancer	0.00025	0.00174	CcSEcCtD
Tranylcypromine—Nausea—Fluorouracil—skin cancer	0.00025	0.00174	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Docetaxel—skin cancer	0.000248	0.00173	CcSEcCtD
Tranylcypromine—Body temperature increased—Docetaxel—skin cancer	0.00024	0.00167	CcSEcCtD
Tranylcypromine—Abdominal pain—Docetaxel—skin cancer	0.00024	0.00167	CcSEcCtD
Tranylcypromine—Asthenia—Docetaxel—skin cancer	0.000218	0.00151	CcSEcCtD
Tranylcypromine—Diarrhoea—Docetaxel—skin cancer	0.000207	0.00144	CcSEcCtD
Tranylcypromine—Dizziness—Docetaxel—skin cancer	0.000201	0.0014	CcSEcCtD
Tranylcypromine—Vomiting—Docetaxel—skin cancer	0.000193	0.00134	CcSEcCtD
Tranylcypromine—Rash—Docetaxel—skin cancer	0.000191	0.00133	CcSEcCtD
Tranylcypromine—Dermatitis—Docetaxel—skin cancer	0.000191	0.00133	CcSEcCtD
Tranylcypromine—Headache—Docetaxel—skin cancer	0.00019	0.00132	CcSEcCtD
Tranylcypromine—Nausea—Docetaxel—skin cancer	0.00018	0.00125	CcSEcCtD
